This HTML report is designed as a professor-facing summary of the pilot results. The code is hidden by default, and the report focuses on the sample, manipulation checks, key dependent-variable results, full 2 × 2 × 2 ANOVA results, and interpretable plots.
| Sample Summary | |
| Raw rows after dropping Qualtrics metadata rows | Final N after attention-check and debrief filters |
|---|---|
| 1102 | 1051 |
| Risk Scale Reliability | |||
| Scale | Cronbach's alpha | Standardized alpha | Number of items |
|---|---|---|---|
| Risk scale: R1, R2, R3 | 0.899 | 0.899 | 3 |
The final analytic sample includes 1051 participants after excluding incomplete/invalid responses, attention-check failures, and participants who did not complete the debrief.
The risk scale showed a Cronbach’s alpha of 0.899, indicating the internal consistency of the three risk items.
For the manipulation checks, the following MC tests were significant at p < .05: MC_3, MC_5, MC_4. The full table below shows which condition each item differed across.
For the dependent variables, at least one simple condition comparison was significant at p < .05. Significant DVs included: Risk (average of R1, R2, R3), Time (T2_1). See the DV results table for the exact condition, means, p-values, and Cohen’s d.
For the full 2 × 2 × 2 model, the three-way interaction was significant for: Time (T1). The corresponding plots are especially important to inspect.
Significance codes used throughout: *** p < .001,
** p < .01, * p < .05, . p
< .10.
This section shows whether the manipulation-check items differed across the relevant experimental conditions. Means and standard deviations are shown within each condition, followed by independent-samples t-tests.
| Manipulation Check Results | ||||||
| Means (SD), sample sizes, and independent-samples t-tests | ||||||
| MC Item | Cell 1: M (SD), n | Cell 2: M (SD), n | t | df | p | |
|---|---|---|---|---|---|---|
| Personalisation: Not Personalised vs. Personalised | ||||||
| MC_1 | Not Personalised: -0.88 (1.75), n=522 | Personalised: -0.77 (1.76), n=529 | -1.04 | 1048.9 | 0.301 | |
| MC_2 | Not Personalised: 1.10 (1.51), n=522 | Personalised: 0.99 (1.58), n=529 | 1.18 | 1047.9 | 0.238 | |
| MC_3 | Not Personalised: -1.42 (1.53), n=522 | Personalised: 0.16 (1.97), n=529 | -14.46 | 994.8 | < .001 | *** |
| MC_4 | Not Personalised: 0.82 (1.75), n=522 | Personalised: 0.88 (1.77), n=529 | -0.53 | 1049.0 | 0.599 | |
| MC_5 | Not Personalised: 0.79 (1.70), n=522 | Personalised: 0.71 (1.80), n=529 | 0.80 | 1047.0 | 0.426 | |
| Schema: Cosmetic vs. Drug | ||||||
| MC_1 | Cosmetic: -0.83 (1.76), n=533 | Drug: -0.82 (1.75), n=518 | -0.01 | 1048.6 | 0.991 | |
| MC_2 | Cosmetic: 1.11 (1.50), n=533 | Drug: 0.98 (1.60), n=518 | 1.40 | 1039.9 | 0.162 | |
| MC_3 | Cosmetic: -0.59 (1.95), n=533 | Drug: -0.67 (1.92), n=518 | 0.66 | 1048.9 | 0.509 | |
| MC_4 | Cosmetic: 0.89 (1.73), n=533 | Drug: 0.80 (1.80), n=518 | 0.86 | 1044.4 | 0.389 | |
| MC_5 | Cosmetic: 0.82 (1.74), n=533 | Drug: 0.68 (1.77), n=518 | 1.28 | 1046.9 | 0.201 | |
| Goal: Prevention vs. Cure | ||||||
| MC_1 | Prevention: -0.92 (1.73), n=504 | Cure: -0.73 (1.77), n=547 | -1.77 | 1045.8 | 0.076 | . |
| MC_2 | Prevention: 1.06 (1.61), n=504 | Cure: 1.04 (1.49), n=547 | 0.22 | 1023.1 | 0.827 | |
| MC_3 | Prevention: -0.67 (1.90), n=504 | Cure: -0.58 (1.96), n=547 | -0.78 | 1046.1 | 0.434 | |
| MC_4 | Prevention: 1.44 (1.50), n=504 | Cure: 0.30 (1.81), n=547 | 11.16 | 1038.7 | < .001 | *** |
| MC_5 | Prevention: 0.05 (1.77), n=504 | Cure: 1.39 (1.48), n=547 | -13.26 | 984.2 | < .001 | *** |
Significance: *** p < .001, ** p < .01, * p < .05, . p < .10. |
||||||
This section shows simple comparisons for each dependent variable across each experimental condition. These are useful for seeing whether any single manipulation moved price, time, or risk perceptions on its own.
| Dependent Variable Results by Condition | |||||||
| Means (SD), sample sizes, t-tests, and Cohen's d | |||||||
| Dependent Variable | Cell 1: M (SD), n | Cell 2: M (SD), n | t | df | p | Cohen's d | |
|---|---|---|---|---|---|---|---|
| Personalisation: Not Personalised vs. Personalised | |||||||
| Price (FP_1) | Not Personalised: 20.09 (14.29), n=522 | Personalised: 19.45 (13.73), n=529 | 0.74 | 1046.0 | 0.461 | 0.05 | |
| Time (T1) | Not Personalised: -0.76 (1.31), n=522 | Personalised: -0.67 (1.30), n=529 | -1.09 | 1048.4 | 0.276 | -0.07 | |
| Time (T2_1) | Not Personalised: 2.98 (1.56), n=522 | Personalised: 2.91 (1.54), n=529 | 0.73 | 1048.2 | 0.466 | 0.05 | |
| Risk (average of R1, R2, R3) | Not Personalised: -0.59 (1.27), n=522 | Personalised: -0.57 (1.33), n=529 | -0.23 | 1048.1 | 0.817 | -0.01 | |
| Schema: Cosmetic vs. Drug | |||||||
| Price (FP_1) | Cosmetic: 19.45 (14.05), n=533 | Drug: 20.09 (13.96), n=518 | -0.75 | 1048.5 | 0.455 | -0.05 | |
| Time (T1) | Cosmetic: -0.75 (1.29), n=533 | Drug: -0.68 (1.31), n=518 | -0.81 | 1046.9 | 0.418 | -0.05 | |
| Time (T2_1) | Cosmetic: 2.99 (1.57), n=533 | Drug: 2.91 (1.53), n=518 | 0.87 | 1049.0 | 0.383 | 0.05 | |
| Risk (average of R1, R2, R3) | Cosmetic: -0.72 (1.29), n=533 | Drug: -0.45 (1.30), n=518 | -3.38 | 1047.5 | < .001 | -0.21 | *** |
| Goal: Prevention vs. Cure | |||||||
| Price (FP_1) | Prevention: 19.02 (14.53), n=504 | Cure: 20.45 (13.48), n=547 | -1.65 | 1024.1 | 0.099 | -0.10 | . |
| Time (T1) | Prevention: -0.75 (1.32), n=504 | Cure: -0.69 (1.28), n=547 | -0.75 | 1036.4 | 0.452 | -0.05 | |
| Time (T2_1) | Prevention: 3.05 (1.58), n=504 | Cure: 2.85 (1.51), n=547 | 2.13 | 1031.8 | 0.034 | 0.13 | * |
| Risk (average of R1, R2, R3) | Prevention: -0.55 (1.31), n=504 | Cure: -0.62 (1.29), n=547 | 0.82 | 1039.0 | 0.412 | 0.05 | |
Significance: *** p < .001, ** p < .01, * p < .05, . p < .10. |
|||||||
Each section below presents the full factorial model for one dependent variable, followed immediately by the matching interaction plot. This keeps the statistical test and visual interpretation together for each DV.
| Full 2 × 2 × 2 ANOVA: Price (FP_1) | |||||||
| Model: DV ~ Personalisation × Schema × Goal | |||||||
| DV | Effect | df | Sum Sq | F | p | Partial eta-squared | |
|---|---|---|---|---|---|---|---|
| Price (FP_1) | Cond1 | 1 | 116.15 | 0.59 | 0.442 | 0.001 | |
| Price (FP_1) | Cond2 | 1 | 81.76 | 0.42 | 0.519 | 0.000 | |
| Price (FP_1) | Cond3 | 1 | 568.31 | 2.90 | 0.089 | 0.003 | . |
| Price (FP_1) | Cond1:Cond2 | 1 | 157.21 | 0.80 | 0.371 | 0.001 | |
| Price (FP_1) | Cond1:Cond3 | 1 | 62.03 | 0.32 | 0.574 | 0.000 | |
| Price (FP_1) | Cond2:Cond3 | 1 | 222.21 | 1.13 | 0.288 | 0.001 | |
| Price (FP_1) | Cond1:Cond2:Cond3 | 1 | 45.94 | 0.23 | 0.629 | 0.000 | |
Type III tests use sum-to-zero contrasts. Significance: *** p < .001, ** p < .01, * p < .05, . p < .10. |
|||||||
| Full 2 × 2 × 2 ANOVA: Time (T1) | |||||||
| Model: DV ~ Personalisation × Schema × Goal | |||||||
| DV | Effect | df | Sum Sq | F | p | Partial eta-squared | |
|---|---|---|---|---|---|---|---|
| Time (T1) | Cond1 | 1 | 1.91 | 1.13 | 0.289 | 0.001 | |
| Time (T1) | Cond2 | 1 | 0.92 | 0.54 | 0.462 | 0.001 | |
| Time (T1) | Cond3 | 1 | 0.95 | 0.56 | 0.455 | 0.001 | |
| Time (T1) | Cond1:Cond2 | 1 | 0.02 | 0.01 | 0.918 | 0.000 | |
| Time (T1) | Cond1:Cond3 | 1 | 0.05 | 0.03 | 0.863 | 0.000 | |
| Time (T1) | Cond2:Cond3 | 1 | 0.51 | 0.30 | 0.583 | 0.000 | |
| Time (T1) | Cond1:Cond2:Cond3 | 1 | 8.42 | 4.97 | 0.026 | 0.005 | * |
Type III tests use sum-to-zero contrasts. Significance: *** p < .001, ** p < .01, * p < .05, . p < .10. |
|||||||
| Full 2 × 2 × 2 ANOVA: Time (T2_1) | |||||||
| Model: DV ~ Personalisation × Schema × Goal | |||||||
| DV | Effect | df | Sum Sq | F | p | Partial eta-squared | |
|---|---|---|---|---|---|---|---|
| Time (T2_1) | Cond1 | 1 | 0.99 | 0.42 | 0.519 | 0.000 | |
| Time (T2_1) | Cond2 | 1 | 2.11 | 0.88 | 0.348 | 0.001 | |
| Time (T2_1) | Cond3 | 1 | 10.58 | 4.42 | 0.036 | 0.004 | * |
| Time (T2_1) | Cond1:Cond2 | 1 | 4.08 | 1.71 | 0.192 | 0.002 | |
| Time (T2_1) | Cond1:Cond3 | 1 | 0.66 | 0.27 | 0.600 | 0.000 | |
| Time (T2_1) | Cond2:Cond3 | 1 | 2.82 | 1.18 | 0.278 | 0.001 | |
| Time (T2_1) | Cond1:Cond2:Cond3 | 1 | 0.44 | 0.18 | 0.668 | 0.000 | |
Type III tests use sum-to-zero contrasts. Significance: *** p < .001, ** p < .01, * p < .05, . p < .10. |
|||||||
| Full 2 × 2 × 2 ANOVA: Risk (average of R1, R2, R3) | |||||||
| Model: DV ~ Personalisation × Schema × Goal | |||||||
| DV | Effect | df | Sum Sq | F | p | Partial eta-squared | |
|---|---|---|---|---|---|---|---|
| Risk (average of R1, R2, R3) | Cond1 | 1 | 0.30 | 0.18 | 0.670 | 0.000 | |
| Risk (average of R1, R2, R3) | Cond2 | 1 | 18.33 | 10.93 | < .001 | 0.010 | *** |
| Risk (average of R1, R2, R3) | Cond3 | 1 | 1.12 | 0.67 | 0.414 | 0.001 | |
| Risk (average of R1, R2, R3) | Cond1:Cond2 | 1 | 0.00 | 0.00 | 0.981 | 0.000 | |
| Risk (average of R1, R2, R3) | Cond1:Cond3 | 1 | 0.32 | 0.19 | 0.663 | 0.000 | |
| Risk (average of R1, R2, R3) | Cond2:Cond3 | 1 | 2.22 | 1.32 | 0.251 | 0.001 | |
| Risk (average of R1, R2, R3) | Cond1:Cond2:Cond3 | 1 | 0.03 | 0.02 | 0.892 | 0.000 | |
Type III tests use sum-to-zero contrasts. Significance: *** p < .001, ** p < .01, * p < .05, . p < .10. |
|||||||
This section gives the raw descriptive means across all eight experimental cells. This is especially useful for interpreting any interaction effects or directional movement in the plots.
| Eight-Cell Means | |||||||||||
| Descriptive statistics by Personalisation × Schema × Goal | |||||||||||
| Cond1 | Cond2 | Cond3 | n | Price M | Price SD | T1 M | T1 SD | T2_1 M | T2_1 SD | Risk M | Risk SD |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Not Personalised | Cosmetic | Prevention | 134 | 18.69 | 14.93 | -0.94 | 1.30 | 3.12 | 1.56 | -0.67 | 1.31 |
| Not Personalised | Cosmetic | Cure | 123 | 20.15 | 13.87 | -0.64 | 1.36 | 2.80 | 1.53 | -0.79 | 1.31 |
| Not Personalised | Drug | Prevention | 131 | 19.52 | 13.86 | -0.65 | 1.34 | 3.09 | 1.61 | -0.49 | 1.30 |
| Not Personalised | Drug | Cure | 134 | 21.99 | 14.37 | -0.80 | 1.24 | 2.90 | 1.54 | -0.44 | 1.14 |
| Personalised | Cosmetic | Prevention | 121 | 19.70 | 15.44 | -0.65 | 1.24 | 3.17 | 1.66 | -0.59 | 1.29 |
| Personalised | Cosmetic | Cure | 155 | 19.35 | 12.26 | -0.74 | 1.27 | 2.88 | 1.53 | -0.80 | 1.25 |
| Personalised | Drug | Prevention | 118 | 18.14 | 13.93 | -0.74 | 1.40 | 2.81 | 1.51 | -0.43 | 1.34 |
| Personalised | Drug | Cure | 135 | 20.47 | 13.56 | -0.56 | 1.28 | 2.81 | 1.44 | -0.43 | 1.41 |